Implications of new European Union driving regulations on patients with Type 1 diabetes who participated in the Diabetes Control and Complications Trial

Diabetic Medicine

Volumn 30, Issue 5, 2013, Pages 616-619

  Kilpatrick, E S ^a   Rigby, A S ^b   Warren, R E ^c   Atkin, S L ^d  

^a HULL ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF HULL   (United Kingdom)

^c ROYAL DEVON AND EXETER HOSPITAL   (United Kingdom)

^d UNIVERSITY OF HULL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; ISOPHANE INSULIN;

ARTICLE; CAR DRIVING; CLINICAL RESEARCH; CORRELATION ANALYSIS; DISEASE DURATION; DISEASE SEVERITY; DRIVER LICENCE; EUROPEAN UNION; GROUPS BY AGE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; LAW; MAJOR CLINICAL STUDY; TRAFFIC ACCIDENT; TRAFFIC SAFETY;

ACCIDENTS, TRAFFIC; ADULT; AUTOMOBILE DRIVING; BLOOD GLUCOSE SELF-MONITORING; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; EUROPEAN UNION; FEMALE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; LICENSURE; MALE; PREVALENCE; RISK FACTORS; SELF ADMINISTRATION;

EID: 84876351851     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12075     Document Type: Article

References (15)

1. Shaw K. Driving and diabetes: new licensing standards by European Union directive. Pract Diabetes Int 2011; 28: 375-376.
2. Cox DJ, Gonder-Frederick LA, Kovatchev BP, Julian DM, Clarke WL. Progressive hypoglycemia's impact on driving simulation performance. Occurrence, awareness and correction. Diabetes Care 2011; 23: 163-170.
3. Cox DJ, Ford D, Gonder-Frederick L, Clarke W, Mazze R, Weinger K et al. Driving mishaps among individuals with type 1 diabetes. Diabetes Care 2009; 32: 2177-2180.
4. European Union (EU). Commission Directive 2009/112/EC of 25 August 2009 amending Council Directive 91/439/EEC on driving licences. OJL 2009; 52: 26-30.
5. European Union (EU). Commission Directive 2009/113/EC of 25 August 2009 amending Directive 2006/126/EC of the European Parliament and of the Council on driving licences. OJL 2009; 52: 31-35.
6. Department for Transport. Proposals to Amend Driving Licence Standards for Vision, Diabetes and Epilepsy Annex III to Directive 91/439/EEC. Annex A Impact Assessment for Proposals to Amend Driving Licence Standards for Diabetes. Available at http://www.dft.gov.uk/dvla/consultations.aspx Last accessed 6 October 2012.
7. Diabetes UK. Response to the Proposal to Amend Driving Licence Standards for Vision, Diabetes and Epilepsy. Annex 3 to Directive 91/439/EEC and 2006/126/EC. Available at http://www.diabetes.org.uk/About_us/Our_Views/Consultations/Past_responses/DVLA-Consultation-on-amending-medical-driving-licence-standards/ Last accessed 6 October 2012.
8. DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
9. DCCT Research Group. Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes 1997; 46: 271-286.
10. Hopkins D, Lawrence I, Mansell P, Thompson G, Amiel S, Campbell M et al. Improved biomedical and psychological outcomes 1 year after structured education in flexible insulin therapy for people with type 1 diabetes: the UK DAFNE experience. Diabetes Care 2012; 35: 1638-1642.
11. Siebenhofer A, Plank J, Berghold A, Jeitler K, Horvath K, Narath M et al. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus. Cochrane Database Syst Rev 2006. Available at www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD003287/frame.html Last accessed 6 October 2012.
12. Horvath K, Jeitler K, Berghold A, Ebrahim S, Gratzer T, Plank J et al. Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus. Cochrane Database Syst Rev 2007; 2: CD005613.
13. Pickup JC, Sutton AJ. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Diabet Med 2008; 25: 765-774.
14. Misso M, Egberts K, Page M, O'Connor D, Shaw J. Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus. Cochrane Database Syst Rev 2010. Available at www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD005103/frame.html Last accessed 6 October 2012.
15. DCCT Research Group. Implementation of treatment protocols in the Diabetes Control and Complications Trial. Diabetes Care 1995; 18: 361.